Anti-Human PCSK9 Recombinant Antibody(Ralpancizumab)
-
产品编号
YR1326
-
别名
科研级 Ralpancizumab ( 雷泮赛珠单抗 ), Anti-PCSK9 Recombinant Antibody, Research Grade Ralpancizumab
-
规格
- 1mg
- 5mg
Alias | 科研级 Ralpancizumab ( 雷泮赛珠单抗 ), Anti-PCSK9 Recombinant Antibody, Research Grade Ralpancizumab |
Catalog Number | YR1326 |
Molecular Name | Ralpancizumab |
Host | Mouse |
Size | 1mg, 5mg |
Clonity | Monoclonal |
Purity | >95% as determined by SDS-PAGE |
Concentration | 1mg/ml |
Antibody Isotype | IgG2 Kappa |
Formulation | PBS, pH7.5 |
Background | Ralpancizumab (INN, development code RN317) is a monoclonal antibody designed for the treatment of dyslipidemia. |
CAS Number | 1407495-04-8 |
Application | Neut, ELISA, IF, IP, FuncS, FCM, ICC |
Storage Condition | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
Remarks | This product is for research use only. |
Shipping Condition | Shipped on ice packs. |
Target | PCSK9[Homo sapiens] |